Multiplex Imaging

This content is brought to you by Abcam, a Danaher Operating Company.

Multiplex imaging of tumor tissue samples significantly enhances biomarker discovery and increases the accuracy of predicting patient therapeutic responses. Abcam provides highly specific, recombinant antibody reagents that support the multiplex imaging of key targets within the tumor microenvironment (TME). Our extensive range of antibodies, targeting both established and emerging immuno-oncology markers, can be effectively applied across various platforms. Additionally, these antibodies can be combined with different labeling solutions to offer a variety of flexible options for multiplex imaging.

Explore this comprehensive approach and the tools needed to gain deeper insights into the TME to improve patient outcomes.